Trial Profile
Once daily dose of Nevirapine (400 mg) versus twice daily dose (200 mg) of Nevirapine - based Highly Active Antiretroviral therapy regimens in Antiretroviral - naive patients with HIV and Tuberculosis infection in India
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 30 Aug 2016
Price :
$35
*
At a glance
- Drugs Nevirapine (Primary) ; Antituberculars; Efavirenz; Lamivudine; Tenofovir
- Indications HIV infections; Tuberculosis
- Focus Therapeutic Use
- 02 Oct 2012 New trial record